Compare COFS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | DNA |
|---|---|---|
| Founded | 1898 | 2008 |
| Country | United States | United States |
| Employees | N/A | 485 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 443.5M | 455.8M |
| IPO Year | 1995 | N/A |
| Metric | COFS | DNA |
|---|---|---|
| Price | $28.41 | $6.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $36.00 | $8.50 |
| AVG Volume (30 Days) | 64.4K | ★ 1.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.01 | N/A |
| Revenue | ★ $227,624,000.00 | N/A |
| Revenue This Year | $22.13 | N/A |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | $13.99 | ★ N/A |
| Revenue Growth | ★ 63.64 | N/A |
| 52 Week Low | $24.89 | $5.00 |
| 52 Week High | $33.58 | $17.58 |
| Indicator | COFS | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 56.40 | 45.00 |
| Support Level | $28.34 | $6.26 |
| Resistance Level | $30.76 | $7.10 |
| Average True Range (ATR) | 0.89 | 0.49 |
| MACD | 0.15 | 0.02 |
| Stochastic Oscillator | 92.89 | 49.12 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.